IP Verse

Jazz Pharmaceutical competitive analysis

Latest publications and patents of Jazz Pharmaceutical New

Explore the latest publications and patents granted to Jazz Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Jazz Pharmaceutical

EP3784283
Oct 23, 2024Cannabidiol Preparations And Its UsesGranted And Under Opposition
EP3710058
Oct 9, 2024Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut SyndromeGranted And Under Opposition
EP3509582
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl CarbamateGranted And Under Opposition
EP2451486
Jan 18, 2023Pegylated L-AsparaginasePatent Maintained As Amended
EP3509581
Nov 9, 2022Formulations Of (RGranted And Under Opposition
EP2968208
Jul 20, 2022Treatment Of CataplexyGranted And Under Opposition
EP3335708
Dec 11, 2019Administration Of Gamma Hydroxybutyrate With Monocarboxylate TransportersRevoked
EP2768484
Jul 24, 2019Lyophilized LiposomesRevoked
EP2961399
Nov 15, 2017Administration Of Gamma Hydroxybutyrate With Monocarboxylate TransportersRevoked

Latest patents of Jazz Pharmaceutical opposed by its competitors

Explore Jazz Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3784283
Oct 23, 2024Cannabidiol Preparations And Its Uses2
EP3710058
Oct 9, 2024Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut Syndrome1
EP3509582
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
EP2451486
Jan 18, 2023Pegylated L-Asparaginase1
EP3509581
Nov 9, 2022Formulations Of (R1
EP2968208
Jul 20, 2022Treatment Of Cataplexy1
EP3335708
Dec 11, 2019Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters4
EP2768484
Jul 24, 2019Lyophilized Liposomes2
EP2961399
Nov 15, 2017Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters3

Latest PTAB cases involving Jazz Pharmaceutical

Discover the latest PTAB cases involving Jazz Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Jazz Pharmaceutical

IPR2016-00738Mar 10, 2016RANBAXYJAZZ PHARMACEUTICALS IRELANDInstitution Denied
IPR2016-00546Feb 2, 2016AMNEAL PHARMACEUTICALSJAZZ PHARMACEUTICALInstitution Denied
IPR2016-00370Dec 22, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSInstitution Denied
IPR2016-00024Oct 7, 2015RANBAXYJAZZ PHARMACEUTICALTerminated-Settled
IPR2016-00002Oct 6, 2015PAR PHARMACEUTICALJAZZ PHARMACEUTICALInstitution Denied
IPR2015-01903Sep 14, 2015PAR PHARMACEUTICALJAZZ PHARMACEUTICALSFinal Written Decision
IPR2015-01815Aug 27, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSFinal Written Decision
IPR2015-01816Aug 27, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSFinal Written Decision
IPR2015-01818Aug 27, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSFinal Written Decision
IPR2015-01820Aug 27, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Jazz Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
JAZZ PHARMACEUTICALS II - 1 - - Non-Active
MATHYS & SQUIRE49 - - - Highly Aggressive